Multiple inflammatory cytokines and angiogenic factors

"Multiple inflammatory cytokines and angiogenic factors" is not the name of a specific molecule or receptor but rather refers collectively to several classes of secreted proteins involved in immune modulation and blood vessel formation. Key pro-inflammatory cytokines commonly referenced in this context are interleukin‑1 beta (IL‑1β), interleukin‑6 (IL‑6), tumor necrosis factor alpha (TNF‑α), interferon gamma (IFNγ), among others. Major angiogenic factors typically include vascular endothelial growth factor A (VEGF-A), placental growth factor (PGF), fibroblast growth factor 2 (FGF2) and platelet-derived growth factor subtypes. These molecules are produced by immune cells as well as stromal/endothelial cells in response to injury or disease states such as chronic inflammation or hypoxia. They play central roles in driving pathological processes including chronic inflammation seen in autoimmune diseases and abnormal neovascularization observed in cancers or diabetic retinopathy. Traditional Chinese Medicine herbs have been reported to modulate the expression levels of these mediators; however, "multiple inflammatory cytokines and angiogenic factors" does not refer to any one canonical drug target but rather an array of related signaling proteins whose collective modulation may underlie therapeutic effects observed with certain herbal interventions[1][2][4].

Other names

Pro-inflammatory cytokines and angiogenic factorsInflammatory cytokines and growth factorsCytokine/angiogenic factor network

As this is not a single target but multiple molecules, mechanisms include: Cytokine inhibition/blockade to reduce inflammation; VEGF pathway inhibition to block angiogenesis.